Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Craig

Showing results (1051-1060 of 1,230) with videos related to

Pageof 123
Sort By:
Thorax|March 29, 2007
Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old childrenS M Willers, G Devereux, L C A Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 studyKenneth R Hande, Anne Hagey, Jordan Berlin, et al.
Medicine and Science in Sports and Exercise|October 3, 2007
The influence of exercise training on inflammatory cytokines and C-reactive proteinLaura K Stewart, Michael G Flynn, Wayne W Campbell, et al.
Pflugers Archiv : European Journal of Physiology|September 10, 2005
Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cellsTheresa J Berndt, Bernhard Bielesz, Theodore A Craig, et al.
Cancer Chemotherapy and Pharmacology|October 14, 2014
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxelJohn Sarantopoulos, Alain C Mita, James L Wade, et al.
Plos One|September 10, 2015
Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder CancerDeepika Dhawan, Melissa Paoloni, Shweta Shukradas, et al.
ACS Omega|November 18, 2024
Democratizing Access to Microfluidics: Rapid Prototyping of Open Microchannels with Low-Cost LCD 3D PrintersKelsey M Leong, Aileen Y Sun, Mindy L Quach, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Physician and stakeholder perceptions of conflict of interest policies in oncologyA Craig Lockhart, Marcia S Brose, Edward S Kim, et al.
Molecular Pharmaceutics|August 2, 2019
Folate Receptor α-Targeted <sup>89</sup>Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast CancerGyu Seong Heo, Lisa Detering, Hannah P Luehmann, et al.
Pageof 123

Showing results (1051-1060 of 1,230) with videos related to

Sort By:
Pageof 123
Thorax|March 29, 2007
Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old childrenS M Willers, G Devereux, L C A Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 studyKenneth R Hande, Anne Hagey, Jordan Berlin, et al.
Medicine and Science in Sports and Exercise|October 3, 2007
The influence of exercise training on inflammatory cytokines and C-reactive proteinLaura K Stewart, Michael G Flynn, Wayne W Campbell, et al.
Pflugers Archiv : European Journal of Physiology|September 10, 2005
Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cellsTheresa J Berndt, Bernhard Bielesz, Theodore A Craig, et al.
Cancer Chemotherapy and Pharmacology|October 14, 2014
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxelJohn Sarantopoulos, Alain C Mita, James L Wade, et al.
Plos One|September 10, 2015
Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder CancerDeepika Dhawan, Melissa Paoloni, Shweta Shukradas, et al.
ACS Omega|November 18, 2024
Democratizing Access to Microfluidics: Rapid Prototyping of Open Microchannels with Low-Cost LCD 3D PrintersKelsey M Leong, Aileen Y Sun, Mindy L Quach, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Physician and stakeholder perceptions of conflict of interest policies in oncologyA Craig Lockhart, Marcia S Brose, Edward S Kim, et al.
Molecular Pharmaceutics|August 2, 2019
Folate Receptor α-Targeted <sup>89</sup>Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast CancerGyu Seong Heo, Lisa Detering, Hannah P Luehmann, et al.
Pageof 123